Revvity EBITDA 2010-2024 | RVTY
Revvity annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Revvity EBITDA for the quarter ending March 31, 2024 was $0.184B, a 24.23% decline year-over-year.
- Revvity EBITDA for the twelve months ending March 31, 2024 was $0.740B, a 39.48% decline year-over-year.
- Revvity 2023 annual EBITDA was $0.74B, a 39.48% decline from 2022.
- Revvity 2022 annual EBITDA was $1.222B, a 24.08% decline from 2021.
- Revvity 2021 annual EBITDA was $1.61B, a 49.89% increase from 2020.
| Revvity Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $740 |
| 2022 | $1,222 |
| 2021 | $1,610 |
| 2020 | $1,074 |
| 2019 | $601 |
| 2018 | $527 |
| 2017 | $409 |
| 2016 | $397 |
| 2015 | $365 |
| 2014 | $279 |
| 2013 | $361 |
| 2012 | $237 |
| 2011 | $212 |
| 2010 | $249 |
| 2009 | $200 |
| Revvity Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $184 |
| 2023-09-30 | $179 |
| 2023-06-30 | $189 |
| 2023-03-31 | $187 |
| 2022-12-31 | $243 |
| 2022-09-30 | $229 |
| 2022-06-30 | $360 |
| 2022-03-31 | $390 |
| 2021-12-31 | $399 |
| 2021-09-30 | $258 |
| 2021-06-30 | $411 |
| 2021-03-31 | $542 |
| 2020-12-31 | $419 |
| 2020-09-30 | $312 |
| 2020-06-30 | $236 |
| 2020-03-31 | $107 |
| 2019-12-31 | $205 |
| 2019-09-30 | $141 |
| 2019-06-30 | $151 |
| 2019-03-31 | $105 |
| 2018-12-31 | $165 |
| 2018-09-30 | $126 |
| 2018-06-30 | $142 |
| 2018-03-31 | $94 |
| 2017-12-31 | $126 |
| 2017-09-30 | $105 |
| 2017-06-30 | $102 |
| 2017-03-31 | $77 |
| 2016-12-31 | $118 |
| 2016-09-30 | $101 |
| 2016-06-30 | $92 |
| 2016-03-31 | $86 |
| 2015-12-31 | $72 |
| 2015-09-30 | $104 |
| 2015-06-30 | $98 |
| 2015-03-31 | $91 |
| 2014-12-31 | $11 |
| 2014-09-30 | $88 |
| 2014-06-30 | $99 |
| 2014-03-31 | $81 |
| 2013-12-31 | $129 |
| 2013-09-30 | $92 |
| 2013-06-30 | $73 |
| 2013-03-31 | $67 |
| 2012-12-31 | $5 |
| 2012-09-30 | $75 |
| 2012-06-30 | $83 |
| 2012-03-31 | $74 |
| 2011-12-31 | $14 |
| 2011-09-30 | $65 |
| 2011-06-30 | $67 |
| 2011-03-31 | $66 |
| 2010-12-31 | $76 |
| 2010-09-30 | $65 |
| 2010-06-30 | $57 |
| 2010-03-31 | $51 |
| 2009-12-31 | $55 |
| 2009-09-30 | $36 |
| 2009-06-30 | $61 |
| 2009-03-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.539B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| Cencora (COR) | United States | $48.051B | 19.18 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.400B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.282B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.771B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.120B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |